MYX mayne pharma group ltd
Add to My Watchlist 3.53% ! $3.01

Charts do shout, page-21

  1. Chartsshout
    520 Posts.
    lightbulb Created with Sketch.  16
    clock Created with Sketch.
    27/03/18
    11:32
    Post #: 32051596
    revenue for Dec 17 qrtr was already 243 million.
    Income Statement Mayne Pharma Group Ltd.
    Net Income

    070M140M
    Column 1 Column 2 Column 3 Column 4 Column 5
    0          
    0-70M-140M-210M
    Column 1 Column 2 Column 3 Column 4 Column 5
    0          
    Dec2015Jun2016Dec2016Jun2017Dec2017
      Dec 2017 5-quarter trend
    1 Net Income Growth -
    Column 1
    0  
    		           
    Sales or Revenue| 243.26 M|
    Column 1 Column 2 Column 3 Column 4 Column 5
    0          
    Sales or Revenue Growth| -|
    Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7
    0              
    EBITDA| +27.55 M|
    Column 1 Column 2
    0    
    [/table]
    MYX Price at posting: 78.5¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Want to reach millions of investors? Get in touch
right-arrow Created with Sketch.
NEWS Read the Latest ASX News here on HotCopper
right-arrow Created with Sketch.
NEWS Watch the Latest Video Interviews here on HotCopper
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
Start T rading
Last
$3.01 		Change
-0.110(3.53%) 		Mkt cap ! $253.4M
Open High Low Volume
$3.14 $3.15 $2.90 696.5K

Buyers (Bids)

Vol. Price($)
10000 $3.00
 

Sellers (Offers)

Price($) Vol.
$3.09 630
Last trade - 16.15pm 28/08/2026 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.